Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 211.21M P/E - EPS this Y 47.30% Ern Qtrly Grth -
Income -117.17M Forward P/E -2.28 EPS next Y 6.90% 50D Avg Chg 30.00%
Sales 3.6M PEG - EPS past 5Y - 200D Avg Chg 119.00%
Dividend N/A Price/Book 1.34 EPS next 5Y - 52W High Chg -10.00%
Recommedations 2.00 Quick Ratio 3.87 Shares Outstanding 20.76M 52W Low Chg 295.00%
Insider Own 1.20% ROA -32.14% Shares Float 10.61M Beta 0.88
Inst Own 88.49% ROE -88.43% Shares Shorted/Prior 1.20M/889.95K Price 2.10
Gross Margin - Profit Margin - Avg. Volume 531,745 Target Price 35.33
Oper. Margin -3,437.97% Earnings Date Aug 8 Volume 406,951 Change -5.83%
About Adverum Biotechnologies, Inc.

Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular diseases. Its lead product candidate is ixoberogene soroparvovec (ADVM-022), a single intravitreal injection gene therapy candidate used for the treatment of patients with wet age-related macular degeneration and diabetic macular edema which is in phase 2 clinical trials. The company is developing ADVM-062 (AAV.7m8-L-opsin), a novel gene therapy product candidate for the treatment of blue cone monochromacy via a single IVT injection. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; GenSight Biologics; Lexeo Therapeutics; and Virovek, Inc. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

Adverum Biotechnologies, Inc. News
05/10/24 Adverum Biotechnologies Reports Q1 2024 Results: A Detailed Look at Financials and Pipeline Progress
05/10/24 Down -19.72% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)
05/09/24 Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights
05/09/24 Are Medical Stocks Lagging Ligand Pharmaceuticals (LGND) This Year?
05/03/24 Adverum Biotechnologies to Participate in Upcoming May Investor Conferences
05/02/24 Adverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
04/25/24 Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting
04/23/24 Has Adverum Biotechnologies (ADVM) Outpaced Other Medical Stocks This Year?
04/19/24 Down -24.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)
04/04/24 Are Medical Stocks Lagging Adverum Biotechnologies (ADVM) This Year?
04/04/24 How Adverum (ADVM) Stock Stands Out in a Strong Industry
04/03/24 Down -28.72% in 4 Weeks, Here's Why Adverum Biotechnologies (ADVM) Looks Ripe for a Turnaround
03/27/24 Down -29.25% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)
03/20/24 Adverum Biotechnologies Reports Encouraging Clinical Progress Amidst Financial Adjustments
03/19/24 Is Adverum Biotechnologies (ADVM) Stock Outpacing Its Medical Peers This Year?
03/18/24 Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates
03/06/24 Turn Pocket Change into Profit: 3 Penny Stocks Ready to Pop
02/28/24 Adverum Biotechnologies to Participate in the TD Cowen 44th Annual Health Care Conference
02/27/24 Stocks on the Launchpad: The Next 3 Market Sensations
02/22/24 Unleash Massive Returns With These 3 Top Penny Stocks
ADVM Chatroom

User Image vaseks9 Posted - 1 hour ago

$PRCH Meanwhile i am looking at $ADVM. Thoughts?

User Image vaseks9 Posted - 4 hours ago

$ADVM Strong buy rating

User Image vaseks9 Posted - 4 hours ago

$ADVM Long at $8 or $7?

User Image Stocksrunner Posted - 6 days ago

Key Technical Indicators: $TDOC, $SPT, $SHOP, $FIVE and $ADVM Enter Oversold Territory, Signaling Potential Buying Opportunities.

User Image RollingDollar Posted - 6 days ago

$ADVM

User Image epsguid Posted - 1 week ago

$ADVM reported a loss of $1.50, consensus was ($1.28) via @eWhispers #epsmiss http://eps.sh/d/advm

User Image Stock_Titan Posted - 1 week ago

$ADVM Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights https://www.stocktitan.net/news/ADVM/adverum-biotechnologies-reports-first-quarter-2024-financial-results-3alz0emf2ggf.html

User Image ctenidae Posted - 1 week ago

@neofeudal Selling Cimerli was brilliant- the gene therapies coming from $ADVM and $FDMT and longer-acting implants like $EYPT are going to crush the monthly injections. Cimerli is a rapidly melting ice cube- I'm glad they got rid of it, and cleaned out problematical debt at the same time. I'm calling management smart here.

User Image intratio Posted - 2 weeks ago

https://www.intratio.com/stock-forecast/ADVM Adverum Biotechnologies, Inc. Our algorithm foretells this stock s price has a poor setup for the immediate future and the stock price is consistent with the company s long-term fundamentals $ADVM

User Image erevnon Posted - 04/30/24

HC Wainwright & Co. initiates coverage on Adverum Biotechnologies $ADVM at Buy rating and a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

User Image AnaChart Posted - 04/29/24

$ADVM https://anachart.com/wp-content/uploads/ana_temp/1714392083_soc-img.jpg

User Image intratio Posted - 04/27/24

$ADVM https://www.intratio.com/stock-forecast/ADVM Our predictive algorithm computed that the market value of this company will not rise in the near future and has no clear long-term directional perspective

User Image intratio Posted - 04/26/24

$ADVM https://www.intratio.com/stock-forecast/ADVM Our trained model lets us believe the value of this equity will not increase any time soon and has no ground to be a long-term opportunity

User Image Stock_Titan Posted - 04/25/24

$ADVM Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting https://www.stocktitan.net/news/ADVM/adverum-biotechnologies-to-present-luna-26-week-phase-2-interim-ncnxajv7wxfl.html

User Image Blackmansmokes Posted - 04/25/24

$ADVM it got to 10 so fast I think $7 might be a bottom.

User Image Blackmansmokes Posted - 04/25/24

$ADVM getting back in since it's under 10

User Image Stonkey Posted - 04/25/24

$ADVM Hopeless POS going straight to zero....

User Image DUMBCLUCK Posted - 04/22/24

$ADVM Will ADVM benefit from OCGN news ?

User Image cthockey2 Posted - 04/20/24

$ADVM

User Image 5556_peacock Posted - 04/18/24

$ADVM

User Image 5556_peacock Posted - 04/18/24

$ADVM

User Image Blackmansmokes Posted - 4 weeks ago

$ADVM almost 10 🥷🏿

User Image Blackmansmokes Posted - 4 weeks ago

$ADVM crickets

User Image RallyRaider Posted - 1 month ago

$ADVM 53% percent of patients free of injections through 3 years! anybody owns this one? I feel like they pull the VKTX move on this one?

User Image RallyRaider Posted - 1 month ago

$ADVM "Vabysmo, Roche's eye disease therapy sales: $2.7 billion) in 2023. aflibercept ( Eylea), produced by Regeneron Pharmaceuticals in collaboration with Bayer, achieved $5.8 billion in sales in the U.S. alone, with its overseas partner Bayer adding another €2.9 billion (about $3.1 billion)​."

User Image JoshThe3rd Posted - 1 month ago

$ADVM added

User Image Blackmansmokes Posted - 1 month ago

$ADVM $12. Come down 2 more dollars 🤞🏾

User Image lmvr2977 Posted - 1 month ago

$ADVM

User Image flinder1f7 Posted - 1 month ago

$ADVM waiting to come to 12$ range to jump In

User Image JoshThe3rd Posted - 1 month ago

$ADVM Let's see if it bounces around offering price 👀

Analyst Ratings
Truist Securities Buy May 15, 24
HC Wainwright & Co. Buy May 10, 24
HC Wainwright & Co. Buy Apr 30, 24
Mizuho Buy Apr 29, 24
Chardan Capital Buy Mar 19, 24
RBC Capital Sector Perform Mar 19, 24
Mizuho Buy Feb 6, 24
Mizuho Buy Nov 2, 23
Truist Securities Buy Sep 5, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Seyedkazemi Setareh Chief Development Of.. Chief Development Officer Sep 15 Sell 1.53 6,201 9,488 47,674 09/18/23
Beckman Richard Chief Medical Office.. Chief Medical Officer Sep 19 Sell 1.0697 4,272 4,570 39,061 09/21/22
Seyedkazemi Setareh Chief Development Of.. Chief Development Officer Sep 19 Sell 1.0696 6,058 6,480 47,875 09/21/22
Soparkar Peter See Remarks section See Remarks section Sep 19 Sell 1.0697 13,305 14,232 273,251 09/21/22
Riley Brigit Chief Scientific Off.. Chief Scientific Officer Sep 19 Sell 1.0697 7,266 7,772 118,734 09/21/22
Fischer Laurent CEO, President and D.. CEO, President and Director Sep 19 Sell 1.0696 41,082 43,941 727,380 09/21/22
Beckman Richard Chief Medical Office.. Chief Medical Officer May 17 Buy 0.8228 10,000 8,228 10,000 05/19/22
D'Souza Rupert Chief Financial Offi.. Chief Financial Officer May 13 Buy 0.84 20,000 16,800 20,850 05/17/22
Fischer Laurent CEO, President and D.. CEO, President and Director Apr 20 Buy 1.112 25,000 27,800 762,462 04/22/22
Soparkar Peter See Remarks section See Remarks section Apr 19 Buy 1.14 21,925 24,994 280,556 04/20/22
Fischer Laurent CEO, President and D.. CEO, President and Director Dec 08 Buy 1.82 25,000 45,500 737,462 12/10/21
PATTERSON LEONE D President and CFO President and CFO Feb 11 Sell 14.12 12,533 176,966 97,955 02/11/21